Intrathecal Baclofen and Spasticity: What Do We Know and What Do We Need to Know?
Document Type
Article
Department
Paediatrics and Child Health (East Africa)
Abstract
BACLOFEN (B-[4-chlorophenyl -GABA; Lioresal) is a synthetic gamma-aminobutyric-acid (GABA) agonist which acts selectively on GABA-B receptors. Baclofen has an inhibitory effect on presynaptic transmitter release by restricting calcium influx into presynaptic terminals'. It appears also to act at postsynaptic terminals, with depression of neuronal activity by increasing potassium conductance2. GABA-B receptors are concentrated in layers II and III of the dorsal grey matter of the spinal cord and at various other sites in the central nervous system, especially the thalamus'.
Publication (Name of Journal)
Developmental Medicine and Child Neurology
Recommended Citation
Armstrong, R.
(1992). Intrathecal Baclofen and Spasticity: What Do We Know and What Do We Need to Know?. Developmental Medicine and Child Neurology, 34(8), 739-745.
Available at:
https://ecommons.aku.edu/eastafrica_fhs_mc_paediatr_child_health/125
Comments
This work was published before the author joined Aga Khan University.